Sandeep  Laumas net worth and biography

Sandeep Laumas Biography and Net Worth

CFO & Chief Bus. Officer of Instil Bio
Dr. Laumas has served as the Chief Financial Officer and Chief Business Officer of Instil Bio since February, 2021 and June 2020, respectively. He began his career at Goldman Sachs & Co. in 1996 in the healthcare investment banking division before transitioning to the healthcare equity research division. He was an analyst at Balyasny Asset Management from 2001-03 and then a Managing Director of North Sound Capital from 2003-07, where he was responsible for the global healthcare investment portfolio. He founded and managed Bearing Circle Capital, an investment partnership, since 2008. Dr. Laumas has served as a member of the board of directors of Bioxcel Therapeutics Inc. since 2017 and a board member of Unicycive Therapeutics Inc. since 2018. He previously served as a board member of 9 Meters Biopharma, Inc. from 2020-21, its Executive Chairman from 2014-20, including its Chief Executive Officer from 2019-20. Dr. Laumas received his A.B. (Chemistry) from Cornell University in 1990, his M.D. from Albany Medical College in 1995, with a research year at the Dana-Farber Cancer Institute and completed his medical internship at the Yale University School of Medicine in 1996.

How old is Sandeep Laumas?

Dr. Laumas is currently 55 years old. There are 1 older executives and no younger executives at Instil Bio. Learn More on Sandeep Laumas' age.

How do I contact Sandeep Laumas?

The corporate mailing address for Dr. Laumas and other Instil Bio executives is CONTINENTAL BUILDING 25 CHURCH STREET, HAMILTON D0, HM1Z. Instil Bio can also be reached via phone at 972-499-3350 and via email at [email protected]. Learn More on Sandeep Laumas' contact information.

Has Sandeep Laumas been buying or selling shares of Instil Bio?

Sandeep Laumas has not been actively trading shares of Instil Bio over the course of the past ninety days. Learn More on Sandeep Laumas' trading history.

Who are Instil Bio's active insiders?

Instil Bio's insider roster includes Bronson Crouch (Chairman & CEO ), and Sandeep Laumas (CFO & Chief Bus. Officer ). Learn More on Instil Bio's active insiders.

Sandeep Laumas Insider Trading History at Instil Bio

See Full Table

Sandeep Laumas Buying and Selling Activity at Instil Bio

This chart shows Dr. Sandeep Laumas's buying and selling at Instil Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Instil Bio Company Overview

Instil Bio logo
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its lead product is ITIL-306, a Co-Stimulatory Antigen Receptor molecule to recognize folate receptor alpha, a tumor-associated antigen that is expressed on various solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $10.37
Low: $10.15
High: $10.43

50 Day Range

MA: $11.41
Low: $10.30
High: $12.59

2 Week Range

Now: $10.37
Low: $6.07
High: $14.00

Volume

19,953 shs

Average Volume

26,347 shs

Market Capitalization

$67.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24